Vulnerability · CVE-2026-62383
nltk versions before 3.10.2 contain a symlink-based arbitrary file read vulnerability in IPIPANCorpusReader methods that bypass nltk.pathsec validation entirely.
Published Aug 22, 2026 · catalog updated Oct 14, 2026 · nltk versions before 3.10.2
Check if you run it
No confirmed exploitation is on record for CVE-2026-62383. EPSS is 0.18%. Act only if a listed version of nltk versions before 3.10.2 is installed.
Gaps on this record
- The stored product name is a package slug. The name on this page is taken from the title (nltk versions before 3.10.2).
- No version range is stored. A customer cannot check an installed version against this record.
- No vendor fix or required action is stored. Compare the linked advisory before you change production.
- Severity
- Medium6.8
- Known exploitation
- Not in CISA/VulnCheck KEV
- EPSS
- 0.18%
- Remediation
- Advisory link
- Affected products
- cpe nltk/nltk
nltk versions before 3.10.2 contain a symlink-based arbitrary file read vulnerability in IPIPANCorpusReader methods that bypass nltk.pathsec validation entirely. Attackers can place a symlink in the corpus root directory and read arbitrary files accessible to the process by calling channels(), domains(), categories(), or fileids() methods with the symlink filename.
Are you affected?
Enter the version you run. The result uses only the ranges stored on this record.
The check returns affected, not affected, or incomplete. It does not guess a version that is missing from the record.
- cpe nltk/nltkversion unspecified
How to fix CVE-2026-62383
Recommended remediation
A patch or advisory reference is linked. Open the original publisher for availability by product version.
Official advisories
What to do
Three questions, each answered from this record only. Confirm the vendor advisory before you patch.
Should you patch?
No confirmed exploitation is on record for CVE-2026-62383. EPSS is 0.18%. Act only if a listed version of nltk versions before 3.10.2 is installed.
Which versions are affected?
Affected version ranges are not on this record. Compare the installed version with the linked vendor advisory before you change production.
What should an analyst verify?
CWE-22: Path Traversal. EPSS 0.18%. There is no CISA KEV listing. No Exploit-DB or Metasploit reference is linked. Use the source links for the original advisory.
Code
The project this record applies to. Exploit listings stay in References.
No public source repository is identified for this product.
Timeline
Detection, updates, and resolution for this record.
Aug 22, 2026 · NIST NVD
Detected
nltk versions before 3.10.2 contain a symlink-based arbitrary file read vulnerability in IPIPANCorpusReader methods that bypass nltk.pathsec validation entirely. Attackers can place a symlink in the corpus root directory and read arbitrary files accessible to the process by calling channels(), domains(), categories(), or fileids() methods with the symlink filename.
Oct 14, 2026 · NIST NVD
Updated
nltk versions before 3.10.2 contain a symlink-based arbitrary file read vulnerability in IPIPANCorpusReader methods that bypass nltk.pathsec validation entirely. Attackers can place a symlink in the corpus root directory and read arbitrary files accessible to the process by calling channels(), domains(), categories(), or fileids() methods with the symlink filename.
Sources
- CVE.orgVulnerability recordCVE-2026-62383
Official CVE identifier
cve.org - FIRST EPSSExploitation probabilityCVE-2026-62383
30-day exploitation probability 0.2%
first.org - NIST NVDVulnerability recordCVE-2026-62383
nltk versions before 3.10.2 contain a symlink-based arbitrary file read vulnerability in IPIPANCorpusReader methods that bypass nltk.pathsec validation entirely. Attackers can place a symlink in the corpus root directory and read arbitrary files accessible to the process by calli
nvd.nist.gov
References
Freshness
Last verified in this catalog Oct 18, 2026. Significant claims (KEV, EPSS, CVSS, affected ranges) come from the source rows above — open the original publisher for the authoritative advisory.